MNNGF (Baijin Life Science Holdings) Cash-to-Debt : 0.68 (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Baijin Life Science Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Baijin Life Science Holdings's cash to debt ratio for the quarter that ended in Sep. 2024 was 0.68.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Baijin Life Science Holdings couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Baijin Life Science Holdings's Cash-to-Debt or its related term are showing as below:

MNNGF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.47 Med: 2.5 Max: No Debt
Current: 0.68

During the past 11 years, Baijin Life Science Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.47. And the median was 2.50.

MNNGF's Cash-to-Debt is ranked better than
57.54% of 1114 companies
in the Retail - Cyclical industry
Industry Median: 0.44 vs MNNGF: 0.68

Baijin Life Science Holdings Cash-to-Debt Historical Data

The historical data trend for Baijin Life Science Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Baijin Life Science Holdings Cash-to-Debt Chart

Baijin Life Science Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

0.87

0.77

0.74

14.98

0.74

Baijin Life Science Holdings Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Cash-to-Debt	Get a 7-Day Free Trial															3.31	14.98	12.16	0.74	0.68

Competitive Comparison of Baijin Life Science Holdings's Cash-to-Debt

For the Luxury Goods subindustry, Baijin Life Science Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baijin Life Science Holdings's Cash-to-Debt Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Baijin Life Science Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Baijin Life Science Holdings's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	4.843	/	(1.346	+	5.197)
	=	0.74

Baijin Life Science Holdings's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.695	/	(1.632	+	6.802)
	=	0.68

Baijin Life Science Holdings (OTCPK:MNNGF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Baijin Life Science Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Baijin Life Science Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (OTCPK:MNNGF) » Definitions » Cash-to-Debt

Traded in Other Exchanges

01466:Hong Kong

Address

66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG

Website

http://www.affluent-partners.com

Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.